TrialIntegrative cancer therapies

The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial.

Liumei Shou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.